Further gastroenterological evaluation attributed the abdominal pain to the potential use of nonsteroidal anti‐inflammatory drugs (NSAIDs) combined with a GLP‐1 receptor agonist, as well as gastroesophageal reflux disease. Here, GLP1R is linked to gastroesophageal reflux disease.